Sarissa Capital Management as of Sept. 30, 2019
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 12 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medicines Company | 26.3 | $210M | 4.2M | 50.00 | |
| Allergan | 22.0 | $175M | 1.0M | 168.29 | |
| Biogen Idec (BIIB) | 18.8 | $150M | 643k | 232.82 | |
| Ironwood Pharmaceuticals (IRWD) | 10.9 | $87M | 10M | 8.58 | |
| Innoviva (INVA) | 8.2 | $66M | 6.2M | 10.54 | |
| Intercept Pharmaceuticals In | 7.1 | $57M | 851k | 66.36 | |
| Jazz Pharmaceuticals (JAZZ) | 3.9 | $31M | 242k | 128.14 | |
| Puma Biotechnology (PBYI) | 1.9 | $15M | 1.4M | 10.76 | |
| Mersana Therapeutics (MRSN) | 0.7 | $5.9M | 3.8M | 1.58 | |
| Regulus Therapeutics | 0.2 | $1.3M | 1.9M | 0.72 | |
| Abbvie (ABBV) | 0.0 | $75k | 1.0k | 75.00 | |
| Mirati Therapeutics | 0.0 | $77k | 1.0k | 77.00 |
